ERBB2 and breast cancer: A subtype of HER2-enriched and luminal B breast cancers are noted for their fast growth and poorer prognosis [6,33] and their high prevalence among the study population may provide a window of explanation to why breast cancer among Africans and Ghanaians are thought to be generally more aggressive [34,35].